HCPCS code J0745: Codeine phosphate injection billing guide

Key Takeaways

HCPCS code J0745 describes an injection of codeine phosphate, per 30 mg, and is used to bill Medicare and other payers for administered doses.

Units are calculated based on the total milligrams administered: a 60 mg dose equals 2 units of J0745.

NDC number reporting is mandatory when billing J0745 to Medicare and Medicaid, and omitting it is a common cause of claim denial.

Pabau’s claims management software helps practices track J-code units, NDC entries, and drug administration billing in one workflow.

HCPCS code J0745 is the Level II code used to bill for an injection of codeine phosphate at a rate of per 30 mg. It belongs to the J-series of HCPCS Level II codes, which cover separately payable injectable and infused drugs administered in physician offices, outpatient hospital settings, and other clinical environments. According to the Centers for Medicare and Medicaid Services (CMS), HCPCS Level II codes like J0745 are maintained annually and updated each January 1.

J0745 carries a Permanent National status and is active for dates of service in the current fiscal year. It falls under Type of Service 1 (Medical Care), which determines how Medicare processes the claim. Before submitting any claim using this code, confirm the current-year status via the CMS HCPCS annual release file, as codes can be revised, replaced, or retired. Setting up medical forms at your practice to capture administered drug details at the point of care reduces the risk of coding errors downstream.

Code description and billing unit calculation for J0745

The unit definition in HCPCS Code J0745 is per 30 mg, meaning one unit equals 30 milligrams of codeine phosphate administered. This is where most billing errors occur. A prescriber administers 60 mg: the biller must submit 2 units. A 90 mg dose requires 3 units. Billing only 1 unit for a 60 mg dose results in underpayment; billing 2 units for a 30 mg dose risks a False Claims Act audit.

Unit calculation formula: Divide the total milligrams administered by 30. Round to the nearest whole unit per CMS drug billing guidance. Never round up to inflate units, and document the administered dose in the patient chart to support the unit count on the claim. EMR platforms for IV therapy and injectable drug practices often include dose tracking fields that automate this calculation.

J0745 medicare reimbursement and fee schedule

Medicare reimburses HCPCS code J0745 under the drug fee schedule as a separately payable drug under Medicare Part B when administered in an eligible outpatient setting. The payment rate is adjusted by the Geographic Practice Cost Index (GPCI), so what a clinic in rural Mississippi receives per unit differs from a clinic in urban California. Rates are updated annually on January 1 and should always be verified through the CMS Physician Fee Schedule lookup tool for your specific locality before making reimbursement projections.

J0745 reimbursement also differs by place of service. Facility rates (hospitals, ambulatory surgical centers) are typically lower than non-facility rates (physician offices, clinics) because facility overhead is separately reimbursed to the institution. Coders must submit the correct Place of Service code to ensure the right rate applies. Mismatching the POS code with the actual setting is a frequent audit trigger.

Payer coverage and prior authorization for HCPCS code J0745

Medicare Part B covers J0745 when codeine phosphate is administered by a provider in an outpatient clinical setting and a covered diagnosis supports medical necessity. Part D (the prescription drug benefit) generally covers oral formulations dispensed at a pharmacy, not injected drugs administered in a clinic. The distinction matters: billing Part D for an in-office injection will result in a coverage mismatch denial.

Medicaid coverage for J0745 varies by state. Most state Medicaid programs follow CMS guidance for J-series injectable drugs, but formulary restrictions and prior authorization requirements differ. Commercial payers handle codeine phosphate injections inconsistently. Many require prior authorization, especially given the controlled substance classification. Meeting med spa compliance requirements around controlled substance documentation helps support PA requests when needed.

• Medicare Part B: Covers in-office and outpatient administered injections when medically necessary
• Medicare Part D: Covers oral dispensed formulations, not in-office injections
• Medicaid: Coverage varies by state; confirm with your state Medicaid formulary before billing
• Commercial payers: Often require prior authorization; check payer policy before administration
• Worker’s Comp / Auto: Coverage and rate schedules vary by state jurisdiction

Covered ICD-10 diagnosis codes for J0745

Medical necessity is the core documentation requirement for J0745 claims. The ICD-10 diagnosis code on the claim must directly support the use of an injectable opioid analgesic. Payers cross-reference the submitted diagnosis against their coverage policies and Local Coverage Determinations (LCDs). Maintaining thorough patient compliance documentation in the chart reduces the risk of a medical necessity denial on audit.

Always confirm the specific ICD-10 codes accepted by your payer’s LCD before submitting. The table above represents commonly used diagnoses, not a comprehensive payer-approved list. Specificity matters: submitting G89.18 (Other acute postprocedural pain) rather than a generic pain code gives the claim more clinical context and reduces denial risk.

Billing guidelines and claim submission for HCPCS code J0745

Correct claim submission for J0745 requires attention to several fields beyond the code and unit count. The Place of Service code, modifier selection, NDC number, and supporting diagnosis all need to be correct simultaneously. A single error in any one field can result in a denial even when the clinical documentation is complete. Practices that manage HIPAA requirements for med spas and outpatient clinics should build drug administration checklists into their billing workflows.

1. Select the correct Place of Service code: POS 11 for physician office, POS 22 for outpatient hospital. This determines your facility vs. non-facility rate.
2. Calculate and enter units: Total mg administered divided by 30. Enter as a whole number in the units field.
3. Report the NDC number: Mandatory for Medicare and Medicaid. Enter in the “Shaded” line of the CMS-1500 or the equivalent EDI loop (2410). Format: 5-4-2 segments with a qualifier of N4 and the unit of measure qualifier (UN for units, GR for grams, ML for milliliters, F2 for international units).
4. Attach the correct diagnosis code: The ICD-10 code must reflect the specific condition that required injectable codeine phosphate, with highest specificity available.
5. Apply modifiers as needed: See the modifier table below for context on which modifiers apply and when.

Modifiers used with J0745

Modifier use with J0745 is payer-specific and setting-dependent. The table below covers the most commonly applied modifiers, but always verify with your specific payer’s drug billing policy before adding a modifier to a J-code claim.

National Drug Code (NDC) reporting requirements

NDC reporting is not optional for J0745. CMS requires NDC submission for all separately payable drugs billed under Medicare Part B and Medicaid. The NDC identifies the exact manufacturer, product, and package size of the codeine phosphate vial used, which supports drug rebate reconciliation and fraud detection. Omitting the NDC or submitting an incorrect one results in an automatic claim denial from most MACs.

The NDC must be the actual lot-traceable NDC from the vial administered, not the packaged kit NDC or a generic lookup value. Keep the drug packaging or pharmacy receipt on file to match the submitted NDC. Using prescription management software that captures NDC numbers at the point of administration reduces this risk significantly. For digital documentation workflows, digital forms for drug administration can capture NDC data as part of the clinical note, making it available for billing without a separate manual lookup.

NDC format on claims: enter as 11 digits in 5-4-2 format (xxxxx-xxxx-xx) with the qualifier N4 in the appropriate field. Include the unit of measure and quantity administered. Reference HIPAA compliance standards for medical offices to ensure your drug administration documentation meets both CMS and security requirements.

Manage injectable drug billing in one place

Pabau's claims management tools help practices track J-code units, capture NDC numbers at the point of service, and submit cleaner claims. See how it works for drug administration billing workflows.

Book a demo

Related HCPCS J-codes for injectable opioids and analgesics

When codeine phosphate injection is not the right choice, or when a payer’s formulary or LCD requires a different drug, coders need to know the related J-codes for injectable opioids and analgesics. Selecting the wrong J-code for the drug actually administered is a billing compliance violation. Practices managing IV therapy EMR software workflows often need to navigate multiple injectable drug codes simultaneously. See also the broader category of injectable drug billing codes for procedure-level context.

J3490 (Unclassified drugs) is a billing option of last resort. Use it only when no specific J-code exists for the drug administered. Claims submitted under J3490 require an invoice and clinical justification attachment and are subject to greater payer scrutiny than claims under specific J-codes like J0745. Verify J-code accuracy using the AAPC HCPCS Level II code reference or PGM Billing’s HCPCS lookup tool.

Conclusion

Billing errors on J0745 are rarely complex, but they are consistent: wrong unit counts, missing NDC numbers, and diagnosis codes that do not clearly support medical necessity. These are the three fields that need to be right every time, for every claim.

Pabau’s claims management software helps practices that administer injectable drugs capture NDC numbers at the point of service, track administered units against prescribed doses, and submit cleaner claims without the manual lookups. To see how it handles drug administration billing workflows, book a demo.

Continue your research

Need help tracking IV therapy drug administration? IV therapy EMR software from Pabau covers drug tracking, consent forms, and clinical notes in one platform.

Looking to go paperless on your drug admin forms? Pabau’s digital forms capture NDC numbers and administered doses at the point of care, feeding directly into billing records.

Managing compliance around injectable drug billing? Med spa compliance requirements covers the documentation standards that apply to controlled substance administration records.

Frequently Asked Questions